We believe that the emergence of Medicine 3.0 – predicative, preventative, personalized, and participatory healthcare – presents an untapped opportunity to build companies focused on effectively delivering customized health outcomes in new and innovative ways. These companies will combine new technologies and scientific insight to significantly improve patient-consumer engagement, building the foundation of a new, proactive paradigm for health: whenever possible, prevent disease rather than wait to cure it.
| Website | http://www.cornucopiancapital.com |
| Employees | 11 (5 on RocketReach) |
| Founded | 2020 |
| Industry | Investment Management |
| Keywords | Healthcare, Personalized Medicine, Health Tech, Predictive Healthcare, Biotechnology, Medical Technology, Preventive Care, Health Outcomes, Health Innovation, Digital Health, Therapeutics, Health Services, Pharmaceutical, Biopharma, Medical Devices, Life Sciences, Clinical Trials, Drug Discovery, Wellness, Investment |
| Competitors | BlackRock, Vanguard, Fidelity Investments, Schwab Advisor Services, Raymond James, T. Rowe Price, Morgan Stanley, J.P. Morgan, Invesco Ltd., State Street Global Advisors +42 more (view full list) |
Looking for a particular Cornucopian Capital employee's phone or email?
Jinny Choi is the General Partner of Cornucopian Capital.
5 people are employed at Cornucopian Capital.
Cornucopian Capital is based in Montclair, New Jersey.